Diversified Healthcare Trust Common Shares of Beneficial Interest - DHC STOCK NEWS

Diversified Healthcare Trust (Nasdaq: DHC) announced amendments to its credit facility, offering needed covenant relief. Key terms include the extension of the Fixed Charge Coverage Ratio waiver until January 15, 2024 and a decrease in the minimum liquidity requirement from $200 million to $100 million. DHC will retain the ability to fund up to $400 million in capital expenditures annually but is restricted from additional real property investments. The credit facility commitments were reduced from $586.4 million to $450 million, and the interest rate premium increased by 40 basis points.

AlerisLife Inc. (Nasdaq: ALR) has agreed to be acquired by ABP Acquisition LLC for $1.31 per share, an 85% premium over its recent average price of $0.71. The total transaction value is approximately $43.8 million, with no financing conditions attached. ABP, controlled by ALR's managing director Adam Portnoy, owns about 6.1% of ALR's shares, while Diversified Healthcare Trust (DHC) holds approximately 31.9% and has consented to the deal. The tender offer is expected to launch soon, with the completion aimed for Q1 2023. The acquisition has been unanimously approved by ALR's Board of Directors, with Citigroup as the financial advisor.

Diversified Healthcare Trust (Nasdaq: DHC) announced the dividend characterization for 2022 tax reporting. The company declared dividends totaling $0.0400 per share for the year. Key dates included declaration on January 13, 2022, and payment on February 17, 2022. The dividends consist of ordinary income, with a section 199A dividend amounting to $0.0056. Shareholders are advised to refer to IRS Form 1099-DIV for tax reporting. As of September 30, 2022, DHC's portfolio was valued at approximately $7.0 billion, covering 379 properties across 36 states and D.C., with over 27,000 senior living units.

Diversified Healthcare Trust (Nasdaq: DHC) announced a regular quarterly cash distribution of $0.01 per common share, amounting to $0.04 annually. This distribution will be paid to shareholders of record by the close of business on January 23, 2023, with payments expected on or about February 16, 2023. As of September 30, 2022, DHC's portfolio was valued at approximately $7.0 billion and included 379 properties across 36 states and Washington, D.C., highlighting its diversified presence in the healthcare real estate sector.

Diversified Healthcare Trust (NASDAQ: DHC) reported a net loss of $81.5 million or $0.34 per share for Q3 2022, reflecting ongoing challenges in its senior housing operating portfolio (SHOP). Despite a strong leasing performance in its office segment, with a 4.7% increase in same property cash basis NOI year-over-year, the SHOP segment faced significant operating expenses due to Hurricane Ian and inflationary pressures. As of September 30, 2022, DHC maintained liquidity with $800.8 million in cash and no significant debt maturities until 2024.

Diversified Healthcare Trust (Nasdaq: DHC) announced a quarterly cash distribution of $0.01 per common share, equivalent to $0.04 annually. This dividend will be payable to shareholders on record as of October 24, 2022, with distribution occurring on or about November 17, 2022. DHC holds a diverse portfolio of healthcare properties valued at approximately $6.9 billion, comprising 378 properties across 36 states and Washington, D.C., totaling about 9 million square feet. The Trust is managed by The RMR Group (Nasdaq: RMR).

Diversified Healthcare Trust (Nasdaq: DHC) will release its third quarter 2022 financial results after market close on November 2, 2022. A conference call led by President Jennifer Francis and CFO Richard Siedel will be held on November 3, 2022, at 10:00 a.m. ET. Participants can join via a dedicated telephone line or listen online. DHC, a real estate investment trust with a $6.9 billion portfolio, operates 378 properties across 36 states, focusing on high-quality healthcare assets. The company is managed by The RMR Group (Nasdaq: RMR), overseeing assets worth over $37 billion.

Diversified Healthcare Trust (Nasdaq: DHC) reported a net loss of $109.4 million or $0.46 per share for Q2 2022, despite a $6.3 million increase in NOI driven by improved senior living occupancy. The company achieved a 23.3% rise in adjusted EBITDAre and saw a 9.1% increase in rental rates on a segment of their Office Portfolio. However, normalized FFO was negative at ($10.4 million) or ($0.04) per share. The balance sheet strengthened with a $108 million equity sale and a $500 million redemption of senior notes, reducing interest expenses by approximately $49 million.

Diversified Healthcare Trust (Nasdaq: DHC) announced the acquisition of a property at 47071 Bayside Parkway, Fremont, CA, for $82 million. This acquisition reflects a GAAP cap rate of 6.5% and adds to DHC’s growing life science portfolio in the San Francisco Bay area. The property, fully leased to Alamar Bioscience through January 2034, spans 89,000 square feet. DHC now owns four life science assets in this market, totaling approximately 327,000 square feet. The company holds assets worth about $6.8 billion across 36 states and D.C.